Study identifier:D5130C00073
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A sequential, open label study to compare the pharmacokinetics, safety and tolerability of Ticagrelor and Venlafaxine given concomitantly in healthy subjects aged 18 to 45 years
drug drug interaction
Phase 1
Yes
Ticagrelor, Venlaflaxin
All
22
Interventional
18 Years - 45 Years
Allocation: N/A
Endpoint Classification: Safety Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science
Verified 01 Sept 2014 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|